Purchase Order 36C24623P0011
- Not listed
- CareDx, Inc. has been awarded a delivery order valued at $491,742.36 by the Department of Veterans Affairs through Veterans Integrated Service Network 9 (VISN 9) for genetic blood testing services for transplant patients. The contract, which carries a firm fixed-price structure with no set-aside designation, will be performed in Brisbane, California and is scheduled for completion by September 22, 2026. This delivery order falls under CareDx's larger Indefinite Delivery Contract with VISN 9,...
- This is a delivery order contract awarded to Caredx, Inc., a for-profit medical diagnostics company based in Brisbane, California. The contract is for the provision of AlloSure kidney testing kits, which are used to assess organ rejection risk in transplant patients. The contract has a total ceiling value of $2,045,340.00 and was awarded by the U.S. Department of Veterans Affairs (VA) through its Veterans Integrated Service Network (VISN) 12. The contract has a performance period ending on...
- Caredx, Inc., a Brisbane, California-based medical technology company specializing in advanced diagnostic solutions for organ transplant patients, was awarded a delivery order valued at $142,037.50 by Veterans Integrated Service Network (VISN) 23 on January 15, 2026. The contract, which carries an ultimate completion date of January 14, 2028, is for AlloSure in-home patient testing services and operates under firm fixed pricing without a set-aside designation. The work will be performed in...
- This federal contract award to Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California, is for the provision of AlloSure kidney testing kits. The award, valued at $676,098.50, is a delivery order contract with a firm fixed price pricing type. The contracting agency is the Department of Veterans Affairs (VA) and the specific VA entity is Veterans Integrated Service Network 12 (VISN 12). The contract is not designated as a set-aside. Caredx has been awarded...
- This is a $193,171.00 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract is for laboratory reference testing services, specifically Caredx's specialized diagnostic solutions for organ transplant patients, including its AlloMap and AlloSure genetic and molecular testing products. The contract has an ultimate completion date of January 14,...
- The Department of Veterans Affairs (VA) has awarded a $18,466.34 firm-fixed-price delivery order contract to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc., to provide AlloMap molecular testing services for heart transplant patient monitoring. This delivery order is placed against a single-award indefinite delivery contract (IDC) valued at $787,000 that Caredx Lab Solutions holds with the VA's Veterans Integrated Service Network 17 (VISN 17), which runs through June 2027. The contract...
- This federal contract award to Caredx, Inc., a for-profit medical testing company, is for the provision of specialized genetic testing services to support organ transplant programs for the U.S. Department of Veterans Affairs (VA). The contract, valued at $529,760.00, is a delivery order awarded under a larger Indefinite Delivery Vehicle (IDV) contract with a $1,963,141.20 ceiling for genetic blood testing services. Caredx will supply the VA with its AlloSure kidney and heart tests, AlloMap heart...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a purchase order valued at approximately $2,842 to Caredx, Inc. doing business as Caredx of Brisbane, California. The firm fixed price contract is to provide ALLOSURE KIDNEY TESTS from September 5-8, 2023 in support of VHA's healthcare programs for veterans. Caredx will deliver the requested medical products to aid in diagnosis and treatment. No subcontractors or set aside...
- This federal contract award is for the provision of TRANSPLANT TESTING KITS by Caredx, Inc., a for-profit organization that specializes in advanced medical testing products and services to support organ transplant programs. The contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA), has a ceiling value of $2,397,593.00 and is structured as a Delivery Order on a Firm Fixed Price basis. The contract does not have a set-aside...
- The federal contract award is for laboratory services provided by Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract, valued at $241,463.75, was awarded by the U.S. Department of Veterans Affairs (VA) to Caredx for the delivery of advanced genetic and molecular testing solutions focused on organ transplant diagnostics. The contract, which has a completion date of January 14, 2026, is a Firm Fixed Price Delivery Order, with no set-aside...
CareDx, Inc. was awarded a $247,578.50 firm fixed price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 6 on October 19, 2022, for AlloSure kidney donor-derived cell-free DNA testing kits. The contract, which carries no set-aside designation, has an ultimate completion date of October 18, 2027, and is performed in Brisbane, California. The solicitation sought quotes for AlloSure Kidney Donor-Derived Cell-Free DNA Testing services to support the Richmond VA Medical Center's testing needs, with kits to be delivered on an as-needed basis and results provided within 72 hours of specimen receipt. The estimated annual requirement was 60 kits, comprising a 12-kit base period and four 12-kit option periods. CareDx is a specialized medical technology company focused on providing advanced diagnostic solutions for organ transplant patients, with core expertise in genetic and molecular testing services that assess organ rejection risks. The company has established a substantial contract portfolio with the VA across multiple regional networks, delivering proprietary testing services including AlloSure kidney and heart tests as well as next-generation sequencing reagents. This purchase order represents one component of CareDx's ongoing support for the VA's comprehensive post-transplant patient monitoring programs, enabling clinical facilities to access critical donor-derived cell-free DNA diagnostics that inform transplant outcome management and patient care protocols.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Q301--Allosure Testing | 36C24622Q1194 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 | Solicitation 1/1 | 9/16/22, 11:24 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00007 | Exercise an Option | $48.3k | 10/8/25 | |
| P00004 | Funding Only Action | $48.6k | 10/16/24 | |
| P00003 | Supplemental Agreement for work within scope | ($2k) | 2/15/24 | |
| P00002 | Exercise an Option | $36.9k | 10/9/23 | |
| Not listed | Not listed | $38.9k | 10/1/22 |